AI In Pathology Market Led To A Lucrative Growth With USD 1,151.55 Million By 2033: Grand View Research Inc.


 The global AI in pathology market size was estimated at USD 168.25 million in 2025 and is projected to reach USD 1,151.55 million by 2033, growing at a CAGR of 27.42% from 2026 to 2033. Growing demand for precision medicine, rising prevalence of chronic diseases, technological advancements are significant factors contributing to market growth.

Moreover, the growing digitization of pathological infrastructure, supportive regulatory progress, and industry partnerships are strengthening the market environment. The growing demand for precision medicine is one of the significant drivers of artificial intelligence in pathology industry. AI facilitates tailored treatments by integrating histopathological image analysis with genomic data to provide more precise disease subtyping and prognosis. For instance, in July 2025, LG AI Research unveiled its upgraded pathology AI model, EXAONE Path 2.0, to enhance cancer diagnosis and drug development. The system combines analysis of both entire slide images and smaller patches to avoid feature collapse and preserve contextual information. Trained on multi-omics data, including DNA, RNA, and whole slide pathology images, the model analyzes genetic mutations, gene expression, and subtle tissue changes with 78.4% prediction accuracy.

Download a free sample copy of the AI In Pathology Market report to understand detailed coverage and inclusions in the final report

In addition, growing funding for AI research and healthcare digital transformation programs, alongside rising adoption of telepathology, support the deployment of AI tools on a large scale. For instance, in March 2025, Proscia secured USD 50 million in funding to accelerate the adoption of its AI-powered Concentriq platform, an AI-driven pathology solution, to integrate more AI capabilities and leverage partnerships with OEMs like Agilent Technologies and Siemens Healthineers. 

Workflow optimization and operational efficiency in laboratories also significantly fuel the adoption of AI pathology solutions. AI-driven automation of routine tasks such as tissue segmentation, cell counting, and measurement reduces manual labor and human error, allowing pathologists to devote more time to complex cases. For instance, in January 2025, Owkin unveiled new insights into digital pathology and AI solutions, highlighting challenges such as rising pathologist burnout due to workload and diagnostic complexity. Their AI diagnostics support quick interpretation of whole slide images, biomarker screening, and patient outcome predictions to enable precision oncology. 

Need deeper insights? Customize this report for your market

Furthermore, industry partnerships are strengthening the market environment. Pharmaceutical companies are collaborating with AI developers to incorporate digital pathology into clinical trials and drug development. For instance, in April 2025, Precision for Medicine and PathAI announced a strategic collaboration to develop novel AI technologies and integrate PathAI’s advanced digital pathology capabilities into Precision for Medicine’s clinical trial and biospecimen operations. Precision for Medicine is expected to leverage PathAI’s AISight image management system and AI algorithms to enhance biospecimen analysis workflows with quality control steps, improving data consistency and reliability. 

 Explore Grand View Horizon to see global and regional level statistics related to the AI In Pathology Market

Key Market Trends & Insights

  • North America AI in pathology industry held the largest share of over 38% of the global market in 2025.
  • The U.S. artificial intelligence in pathology industry held the largest market share in 2025.
  • By component, the software segment held the largest market share of 51.20% in 2025.
  • By technology, the machine learning segment held the largest market share of 35.65% in 2025.
  • By application, the drug discovery & research pathology segment held the largest market share of 36.30% in 2025.
  • By end use, the life sciences companies segment held the largest market share of 47.51% in 2025.

Explore our Interactive market dashboard to get a bird's-eye view of the AI In Pathology Market. Perform cross-segment analysis, look at market numbers pertaining to specific segments, geographies & timelines, and download these data points in image format that can be used in decks and presentations.

Key AI In Pathology Company Insights

Key players operating in the artificial intelligence in pathology industry are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as new product launches and partnerships play a key role in propelling market growth.

Key AI In Pathology Companies:

The following key companies have been profiled for this study on the AI in pathology market.

  • Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
  • Koninklijke Philips N.V.
  • Hoffmann-La Roche Ltd.
  • PathAI
  • Proscia Inc.
  • Aiforia/ Aiforia Technologies PLC
  • Ibex Medical Analytics
  • Mindpeak GmbH
  • Owkin, Inc.
  • Tempus AI
  • Indica Labs, LLC.
  • Qritive

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

  • Focused market intelligence reports on specific geographies or high-growth segments.
  • Extended forecast timelines for long-term planning.
  • Competitor Benchmarking and Supply Chain Analysis
  • Inclusion of regulatory and policy assessments.
  • Inclusion of custom data models, KPIs, or applications unique to your business
  • Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Discover Our New Consumer Insights Service : https://www.grandviewresearch.com/services/consumer-insights

Comments

Post a Comment

Popular posts from this blog

Veterinary Services Market Projected To Raise At USD 212.73 Billion By 2030

Image
  San Francisco, 31 January 2025:  The Report  Veterinary Services Market  Size, Share & Trends Analysis Report By Service Type (Non-medical, Medical), By Animal Type (Companion, Production), By Region, And Segment Forecasts, 2023 - 2030 The global veterinary services market size is projected to reach USD 212.73 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.45% from 2023 to 2030.Some of the key factors propelling the market growth include increasing animal welfare activities, the rising need to enhance food security, increasing pet population, growing awareness about animal health & timely diagnosis & treatments, and increasing expenditure on animal healthcare services. For instance, according to the American Pet Products Association (APPA), overall spending in the U.S. pet industry was estimated at USD 136.8 billion in 2022. This was notably greater than the USD 123.6 billi...
Read more

Pharmacovigilance Market Overview By Service Provider, Product Life Cycle, Type, Process Flow, Therapeutic Area, End Use, Region And Forecast

Image
  San Francisco, 5 Novembers 2025:  The Report  Pharmacovigilance Market  (2025 - 2030) Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider (In-house, Contract Outsourcing), By Type, By Therapeutic Area, By Process Flow, By End Use, By Region, And Segment Forecasts The global pharmacovigilance market size is projected to reach USD 11.78 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to witness growth at a CAGR of 6.5% from 2025 to 2030. The key factor responsible for the market growth is the growing incidence of Adverse Drug Reactions (ADR). ADR imposes a significant load on healthcare systems and is one of the evident grounds for morbidity in developed nations. As per the National Center for Biotechnology Information (NCBI), about 1 in 20 hospitalizations in Europe yearly are owing to ADR. Pharmacovigilance (PV) services play a vital role in the clinical trial phase by aiding manufacturers in...
Read more

Allergy Diagnostics Market Size Is Expected To Reach USD 11.63 Billion By 2030

Image
  San Francisco, 17 Novembers 2025:  The Report  Allergy Diagnostics Market  (2025 - 2030) Size, Share & Trends Analysis Report By Products And Services (Instruments, Consumables), By Allergen (Food, Inhaled, Drugs), By Test Type (In Vivo Test, In Vitro Test), By End Use (Hospital & Clinics), By Region, And Segment Forecasts The global allergy diagnostics market size is expected to reach USD 11.63 billion by 2030, registering a CAGR of 10.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. Allergies continue to be a significant public health concern in the U.S. and worldwide, affecting both children and adults across all demographics. According to the CDC’s 2023 National Health Interview Survey (NHIS), approximately 25.7% of adults and 18.9% of children in the U.S. reported being diagnosed with seasonal allergies, eczema, or food allergies. This data highlights the growing prevalence of allergic conditions, reflecting an ur...
Read more